EN-3001

N/A

Report date: 2023/03/12 14:23:31
NME

Base Information

Drug NameEN-3001
Drug Alias NameEN-3001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B antagonists
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsAutoimmune Diseases of the Nervous SystemNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnosi Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesEnosi Life Sciences Corp
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases of the Nervous SystemNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A